Investor Presentation
│
•
•
•
•
•
•
↑
↑
•
•
•
→
→
→
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
15
ā
•
–
–
–
–
–
–
•
–
–
–
–
•
•
•
•
•
•
•
•
–
–
•
–
–
–
–
•
–
–ā
•
•
•
–
–
–
–
–
•
•
•
•
•
–
•
–
–
•
•
–
–
•
•
•
•
•
•
•
–
–
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AFT — AFT Pharmaceuticals Limited: AFT Annual Meeting 2018 Presentation2018-08-02
“AFTPHARMACEUTICALS Annual Meeting 3 August 2018 Annual Meeting 2 August 2018 1 IMPORTANT NOTICE This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”), to provide a general overview of AFT. It is not prepared for any other purpose and must not be provided to…”
- SML — Synlait Milk Limited: Synlait October Conference Presentation2018-10-24
“A PORTFOLIO OF INFANT FORMULA CUSTOMER PARTNERSHIPS - Registration with State Administration for Market Regulation (SAMR - the replacement organisation for CFDA) received in FY18 - Exclusive supplier of the a2 Milk Company’s TM infant formula to China and Australasia mar…”
- SML — Synlait Milk Limited: Synlait extends supply agreement with The a2 Milk Company2018-07-02
“Synlait Milk Ltd 1028 Heslerton Road RD13, Rakaia 7783 Private Bag 806 Ashburton 7740 New Zealand P +64 3 373 3000 www.synlait.com Page 1 of 2 SYNLAIT MILK LIMITED NZX: SML ANNOUNCEMENT ASX: SM1 3 JULY 2018 SYNLAIT EXTENDS SUPPLY AGREE…”